Provided by Tiger Trade Technology Pte. Ltd.

AbbVie

203.80
-1.2700-0.62%
Volume:2.11M
Turnover:433.04M
Market Cap:360.19B
PE:86.36
High:208.62
Open:208.06
Low:203.24
Close:205.07
52wk High:244.81
52wk Low:164.39
Shares:1.77B
Float Shares:1.76B
Volume Ratio:0.40
T/O Rate:0.12%
Dividend:6.65
Dividend Rate:3.26%
EPS(TTM):2.36
EPS(LYR):2.36
ROE:6225.00%
ROA:9.81%
PB:-110.15
PE(LYR):86.36

Loading ...

Mar 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 05, 2026

Major Issues Report

Form 8-K - Current report
Mar 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 26, 2026

Major Issues Report

Form 8-K - Current report
Feb 26, 2026

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Feb 25, 2026

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Feb 25, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 20, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 04, 2026

Major Issues Report

Form 8-K - Current report
Jan 07, 2026

Major Issues Report

Form 8-K - Current report
Nov 04, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 31, 2025

Major Issues Report

Form 8-K - Current report
Oct 03, 2025

Major Issues Report

Form 8-K - Current report
Sep 11, 2025

Major Issues Report

Form 8-K - Current report
Aug 22, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 08, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 04, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]